Publications by authors named "Jenny Craigen"

Claim this Profile
D
Development and validation of an LC-MS/MS method for the quantification of novel therapeutic TT-478, a selective adenosine receptor 2B antagonist, for a phase I/II clinical trial.
Daniel Whitaker, Laura Francis, Sami Karaborni, Steven Smith, Jenny L Craigen

Bioanalysis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of an ELISA method for quantification of the anti-HER3 antibody HMBD-001 in human serum.
Oladipo S Idowu, Jenny L Craigen, Gareth J Veal, David Jamieson

Bioanalysis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-IL-7 receptor α monoclonal antibody (GSK2618960) in healthy subjects - a randomized, double-blind, placebo-controlled study.
Joanne Ellis, Andre van Maurik, Lea Fortunato, Sophie Gisbert, Keguan Chen, Jenny L Craigen

Br J Clin Pharmacol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of B cell maturation antigen as a target for antibody drug conjugate mediated cytotoxicity in multiple myeloma.
Lydia Lee, Danton Bounds, Jennifer Paterson, Gaelle Herledan, Katherine Sully, Jenny L Craigen

Br J Haematol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma.
Yu-Tzu Tai, Patrick A Mayes, Chirag Acharya, Mike Y Zhong, Michele Cea, Jenny Craigen

Blood· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneously administered ofatumumab in rheumatoid arthritis: a phase I/II study of safety, tolerability, pharmacokinetics, and pharmacodynamics.
Regina Kurrasch, Judith C Brown, Myron Chu, Jenny Craigen, Philip Overend

J Rheumatol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-cell depletion attenuates white and gray matter pathology in marmoset experimental autoimmune encephalomyelitis.
Yolanda S Kap, Jan Bauer, Nikki van Driel, Wim K Bleeker, Paul W H I Parren, Jenny L Craigen

J Neuropathol Exp Neurol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late B cell depletion with a human anti-human CD20 IgG1κ monoclonal antibody halts the development of experimental autoimmune encephalomyelitis in marmosets.
Yolanda S Kap, Nikki van Driel, Erwin Blezer, Paul W H I Parren, Wim K Bleeker, Jenny L Craigen

J Immunol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of homologous rather than heterologous antigen-specific CD4 T cell responses is critical for functional CD8 T cell responses in mice transgenic for a foreign antigen.
Nicolas Sabarth, Louise Chamberlain, Sara Brett, John Tite, Jenny Craigen

J Immunol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis